Beruflich Dokumente
Kultur Dokumente
Introduction
15% of all clinically recognised pregnancies end in a pregnancy failure. Only 30% of all conceptions result in a live birth. Epidemiologic studies have revealed that 1% to 2% of women experience recurrent pregnancy loss. Based on the incidence of sporadic pregnancy loss, the incidence ofrecurrent pregnancy loss should be approximately 1 in 300 pregnancies.
Definition
3 consecutive pregnancy losses prior to 20 weeks from the last menstrual period. (Recurrent miscarriage or habitual abortion)
Primer
Sekunder
Etiology of RPL
RPL
Explained
Un-explained
Genetic factors
Infective agents
Enviromental factors
Immune factors
Body
Genetic Etiology
Chromosomal
Fetal chromosomal abnormalities
Parental balanced chromosomal rearrangement
Anatomical Etiologies
Septate uterus Intrauterine adhesions Bicornuate ut (unequal horns) Unicornuate uterus T shaped uterus Submucous fibroids Large endometrial polyps
Uterine Abnormalities
CONGENITAL (Mullerian Duct abnormalities)
UTERINE NEOPLASMS (Growth) IATROGENIC (Acquired)
Septate Uterus
Dr.P.M.GOPINATH Director of Social Obstetrics i/c ISO & KGH Chennai 600005
Unicornuate Uterus
Agenesis or hypoplasia of one Mullerian duct
Dr.P.M.GOPINATH Director of Social Obstetrics i/c ISO & KGH Chennai 600005
Uterus Didelphys
Failure of lateral fusion of uterus &vagina
Dr.P.M.GOPINATH Director of Social Obstetrics i/c ISO & KGH Chennai 600005
Bicornuate Uterus
Incomplete fusion of Uterine horns at level of fundus
Dr.P.M.GOPINATH Director of Social Obstetrics i/c ISO & KGH Chennai 600005
Arcuate Uterus
Dr.P.M.GOPINATH Director of Social Obstetrics i/c ISO & KGH Chennai 600005
T shaped Uterus
Diethylstilbestrol treatment T-Shaped uterus, small uterus, constriction rings, Cervical hypoplasia, cervical incompetence,
Dr.P.M.GOPINATH Director of Social Obstetrics i/c ISO & KGH Chennai 600005
2. Uterine Neoplasms
Endometrial Polyps
4/10/2013
3. Iatrogenic
Intrauterine adhesions ,Ashermans Syndrome Lead to Poor implantation, Decreased blood supply , infection
Incompetent Cervix
Endocrine Etiologies
Luteal phase defect (LPD), Polycystic ovarian syndrome (PCOS), Diabetes mellitus, Thyroid disease, and Hyperprolactinemia
Infectious Etiology
Female Viral infections
Coxasackie B Parovo-virus B
Bacterial infections
Bacterial Vaginosis Tuberculosis Chlamydia trachomatis
TORCH infections
Male factors:
Semen infections
Immunologic etiology
Secondary to autoimmune disease such as SLE, etc Primary Antiphospholipid Syndrome (PAPS) refers to the association of adverse pregnancy outcome and presence of antiphospholipid antibodies
APS is characterized by the presence of at least 1 clinical and 1 laboratory criterion : Clinical : 1 or more confirmed episodes of vascular thrombosis (venous, arterial, or small vessel) Pregnancy complications including either 3 or more consecutive pregnancy losses at less than 10 weeks of gestation, 1 or more fetal deaths at greater than 10 weeks of gestation, or at least 1 preterm birth (< 34 weeks) due to severe preeclampsia or placental insufficiency.
APS
Laboratory (repeated at least 2 times, more than 12 weeks apart) : Positive plasma levels of the anticardiolipin antibodies (IgG or IgM) at medium to high levels Positive plasma levels of the lupus anticoagulant
Thrombotic Etiologies
The Herritable thrombophillias : Hyperhomocysteinemia resulting from MTHFR mutations, Activated protein C resistance associated with factor V Leiden mutations, Protein C and protein S deficiencies, Prothrombin promoter mutations, and antithrombin mutations.
Environmental Etiologies
Exogenous causes
organic solvents, medications, ionizing radiation, and toxins smoking, alcohol, and caffeine
Diagnosis
Therapy
Unexplained Etiologies
Progesterone has been shown to be beneficial in decreasing the miscarriage rate among women who have experienced at least 3 losses. LDA. Antenatal counseling and psychological support.
Conclusion
Diagnostic evaluation RPL should include maternal and paternal karyotypes, assessment of the uterine anatomy, and evaluation for thyroid dysfunction, APS, and selected thrombophilias. Evaluation for insulin resistance, ovarian reserve, antithyroid antibodies, and prolactin disorders. Therapy should be directed toward any treatable etiology.
References
Holly BF and Danny JS. Recurrent Pregnancy Loss : Etiology, Diagnosis, and Therapy. Rev Obstet Gynecol. 2009;2(2):76-83. Dr.P.M.GOPINATH Director of Social Obstetrics i/c ISO & KGH Chennai 600005.
THANK YOU
for your valuable time